What is Drug Manufacturing

The pharmaceutical industry is under severe pressure due to complex supply chains that are underutilized, inefficient, and ill-equipped to cope with the sort of products. The pharma supply chain must meet the demands of a fast-evolving marketplace and the shift from patient to an outcome to undergo a radical overhaul. Research and development (R&D) costs in the pharma industry are spiraling, development timelines are growing, and consumers are becoming increasingly knowledgeable about care options including drugs and treatment. The marketplace is fixed through the development cycle and increasing efficiency through rationalization or outsourcing of non-core activities. Recently, the pharma industry moved from the “one-size-fits-all” approach for the supply chain flexibility, responsiveness, and reliability. This chapter enables readers to understand the techniques for rapid commission and decommission new products and markets and alternate supply models, inventory tracking tools to eliminate counterfeiting and parallel-importing risks.